Target type: biologicalprocess
Any process that modulates the frequency, rate or extent of white fat cell proliferation. [GOC:mah, GOC:sl]
White fat cell proliferation, also known as adipogenesis, is a complex and tightly regulated process that is crucial for maintaining energy homeostasis and overall health. The regulation of white fat cell proliferation involves a complex interplay of transcription factors, signaling pathways, and environmental cues.
**1. Transcriptional Regulation:**
* **PPARγ (Peroxisome proliferator-activated receptor gamma):** PPARγ is a master regulator of adipogenesis. It is activated by ligands such as fatty acids and thiazolidinediones (TZDs). Upon activation, PPARγ induces the expression of genes involved in adipocyte differentiation, including lipoprotein lipase (LPL), fatty acid binding protein (FABP), and adiponectin.
* **C/EBPα (CCAAT/enhancer-binding protein alpha):** C/EBPα is another key transcription factor that plays a crucial role in adipogenesis. It is induced by PPARγ and interacts with PPARγ to regulate the expression of genes involved in lipid metabolism and adipocyte differentiation.
* **SREBP1 (Sterol regulatory element binding protein 1):** SREBP1 is a transcription factor that promotes lipid biosynthesis and lipogenesis. It is activated by PPARγ and C/EBPα.
**2. Signaling Pathways:**
* **Insulin/IGF-1 signaling:** Insulin and insulin-like growth factor 1 (IGF-1) promote adipogenesis by activating the PI3K/AKT pathway. AKT phosphorylates and inhibits GSK3β, which is a negative regulator of adipogenesis.
* **Wnt signaling:** Wnt signaling can both promote and inhibit adipogenesis depending on the specific Wnt ligands and downstream targets. Some Wnt ligands promote adipogenesis by activating β-catenin signaling, while others inhibit adipogenesis by activating the Wnt/PCP pathway.
* **BMP signaling:** Bone morphogenetic protein (BMP) signaling is another important pathway that regulates adipogenesis. BMPs can either promote or inhibit adipogenesis depending on the specific BMP ligands and downstream targets.
**3. Environmental Cues:**
* **Nutrients:** Dietary fat and glucose promote adipogenesis by providing substrates for lipid synthesis and energy storage.
* **Hormones:** Leptin and adiponectin, hormones secreted by adipose tissue, can regulate adipogenesis in a negative feedback loop. Leptin inhibits adipogenesis, while adiponectin promotes it.
* **Stress:** Chronic stress can promote adipogenesis through activation of the hypothalamic-pituitary-adrenal (HPA) axis.
**4. Epigenetic Regulation:**
* **DNA methylation:** DNA methylation can play a role in regulating the expression of genes involved in adipogenesis.
* **Histone modifications:** Histone modifications, such as acetylation and methylation, can alter the accessibility of genes to transcription factors and influence gene expression.
**5. Microenvironment:**
* **Adipocyte-stromal vascular fraction (ASC):** ASCs are a heterogeneous population of cells that reside in the adipose tissue and contribute to the regulation of adipogenesis.
* **Extracellular matrix (ECM):** The ECM provides structural support and regulates cell behavior, including adipogenesis.
**Conclusion:**
The regulation of white fat cell proliferation is a complex process that involves a complex interplay of transcription factors, signaling pathways, environmental cues, and epigenetic mechanisms. Understanding the molecular mechanisms that regulate adipogenesis is crucial for developing new therapeutic strategies for obesity and related metabolic diseases.'
"
Protein | Definition | Taxonomy |
---|---|---|
Alpha-ketoglutarate-dependent dioxygenase FTO | An alpha-ketoglutarate-dependent dioxygenase FTO that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9C0B1] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
citric acid, anhydrous | citric acid : A tricarboxylic acid that is propane-1,2,3-tricarboxylic acid bearing a hydroxy substituent at position 2. It is an important metabolite in the pathway of all aerobic organisms. Citric Acid: A key intermediate in metabolism. It is an acid compound found in citrus fruits. The salts of citric acid (citrates) can be used as anticoagulants due to their calcium chelating ability. | tricarboxylic acid | antimicrobial agent; chelator; food acidity regulator; fundamental metabolite |
malic acid | 2-hydroxydicarboxylic acid : Any dicarboxylic acid carrying a hydroxy group on the carbon atom at position alpha to the carboxy group. malic acid : A 2-hydroxydicarboxylic acid that is succinic acid in which one of the hydrogens attached to a carbon is replaced by a hydroxy group. | 2-hydroxydicarboxylic acid; C4-dicarboxylic acid | food acidity regulator; fundamental metabolite |
pyruvic acid | pyruvic acid : A 2-oxo monocarboxylic acid that is the 2-keto derivative of propionic acid. It is a metabolite obtained during glycolysis. Pyruvic Acid: An intermediate compound in the metabolism of carbohydrates, proteins, and fats. In thiamine deficiency, its oxidation is retarded and it accumulates in the tissues, especially in nervous structures. (From Stedman, 26th ed) | 2-oxo monocarboxylic acid | cofactor; fundamental metabolite |
2,4-pyridinedicarboxylic acid | lutidinic acid : A pyridinedicarboxylic acid carrying carboxy groups at positions 2 and 4. | pyridinedicarboxylic acid | |
d-glutamate | D-alpha-amino acid; glutamic acid | Escherichia coli metabolite; mouse metabolite | |
glutamic acid | glutamic acid : An alpha-amino acid that is glutaric acid bearing a single amino substituent at position 2. Glutamic Acid: A non-essential amino acid naturally occurring in the L-form. Glutamic acid is the most common excitatory neurotransmitter in the CENTRAL NERVOUS SYSTEM. | glutamic acid; glutamine family amino acid; L-alpha-amino acid; proteinogenic amino acid | Escherichia coli metabolite; ferroptosis inducer; micronutrient; mouse metabolite; neurotransmitter; nutraceutical |
d-lactic acid | (R)-lactic acid : An optically active form of lactic acid having (R)-configuration. | 2-hydroxypropanoic acid | Escherichia coli metabolite; human metabolite |
d-2-hydroxyglutarate | (R)-2-hydroxyglutaric acid : The (R)-enantiomer of 2-hydroxyglutaric acid. | 2-hydroxyglutaric acid | algal metabolite |
alpha-hydroxyglutarate, (l)-isomer | 2-hydroxyglutaric acid | ||
fumaric acid | fumaric acid : A butenedioic acid in which the C=C double bond has E geometry. It is an intermediate metabolite in the citric acid cycle. fumaric acid: see also record for ferrous fumarate; use FUMARATES for general fumaric acid esters | butenedioic acid | food acidity regulator; fundamental metabolite; geroprotector |
5-carboxy-8-hydroxyquinoline | 5-carboxy-8-hydroxyquinoline: a JmjC histone demethylase inhibitor; structure in first source | quinolines | |
aconitic acid | cis-aconitic acid : The cis-isomer of aconitic acid. | aconitic acid | fundamental metabolite |
oxalylglycine | N-oxalylglycine : An amino dicarboxylic acid that is iminodiacetic acid with an oxo substituent. It is used as an inhibitor of alpha-ketoglutarate dependent (EC 1.14.11.*) enzymes. oxalylglycine: structure given in first source | amino dicarboxylic acid; N-acylglycine | EC 1.14.11.* (oxidoreductase acting on paired donors, 2-oxoglutarate as one donor, incorporating 1 atom each of oxygen into both donors) inhibitor |
entacapone | entacapone : A monocarboxylic acid amide that is N,N-diethylprop-2-enamide in which the hydrogen at position 2 is substituted by a cyano group and the hydrogen at the 3E position is substituted by a 3,4-dihydroxy-5-nitrophenyl group. entacapone: structure given in first source | 2-nitrophenols; catechols; monocarboxylic acid amide; nitrile | antidyskinesia agent; antiparkinson drug; central nervous system drug; EC 2.1.1.6 (catechol O-methyltransferase) inhibitor |
fg-4592 | roxadustat : An N-acylglycine resulting from the formal condensation of the amino group of glycine with the carboxy group of 4-hydroxy-1-methyl-7-phenoxyisoquinoline-3-carboxylic acid. It is an inhibitor of hypoxia inducible factor prolyl hydroxylase (HIF-PH). roxadustat: structure in first source | aromatic ether; isoquinolines; N-acylglycine | EC 1.14.11.2 (procollagen-proline dioxygenase) inhibitor; EC 1.14.11.29 (hypoxia-inducible factor-proline dioxygenase) inhibitor |